Figure 1.

RAS signature score relationship to Kras mutation status. RAS signature scores relative to KRAS mutation status in (A) lung cancer cell lines, (B) breast cancer cell lines, and (C) lung tumors. The Y-axis shows the RAS pathway signature score relative to the mean of all samples in the experiment. Samples in red are KRAS mutant, samples in blue are KRAS wild-type

Loboda et al. BMC Medical Genomics 2010 3:26   doi:10.1186/1755-8794-3-26
Download authors' original image